BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10096859)

  • 1. Tumonoic acids, novel metabolites from a cyanobacterial assemblage of Lyngbya majuscula and Schizothrix calcicola.
    Harrigan GG; Luesch H; Yoshida WY; Moore RE; Nagle DG; Biggs J; Park PU; Paul VJ
    J Nat Prod; 1999 Mar; 62(3):464-7. PubMed ID: 10096859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation, structure determination, and biological activity of dolastatin 12 and lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblages.
    Harrigan GG; Yoshida WY; Moore RE; Nagle DG; Park PU; Biggs J; Paul VJ; Mooberry SL; Corbett TH; Valeriote FA
    J Nat Prod; 1998 Oct; 61(10):1221-5. PubMed ID: 9784156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and structure determination of lyngbyastatin 3, a lyngbyastatin 1 homologue from the marine cyanobacterium Lyngbya majuscula. Determination of the configuration of the 4-amino-2,2-dimethyl-3-oxopentanoic acid unit in majusculamide C, dolastatin 12, lyngbyastatin 1, and lyngbyastatin 3 from cyanobacteria.
    Williams PG; Moore RE; Paul VJ
    J Nat Prod; 2003 Oct; 66(10):1356-63. PubMed ID: 14575437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somamides A and B, two new depsipeptide analogues of dolastatin 13 from a Fijian cyanobacterial assemblage of Lyngbya majuscula and Schizothrix species.
    Nogle LM; Williamson RT; Gerwick WH
    J Nat Prod; 2001 Jun; 64(6):716-9. PubMed ID: 11421730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carmabins A and B, new lipopeptides from the Caribbean cyanobacterium Lyngbya majuscula.
    Hooper GJ; Orjala J; Schatzman RC; Gerwick WH
    J Nat Prod; 1998 Apr; 61(4):529-33. PubMed ID: 9584405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apramides A-G, novel lipopeptides from the marine cyanobacterium Lyngbya majuscula.
    Luesch H; Yoshida WY; Moore RE; Paul VJ
    J Nat Prod; 2000 Aug; 63(8):1106-12. PubMed ID: 10978206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symplostatin 2: a dolastatin 13 analogue from the marine cyanobacterium Symploca hydnoides.
    Harrigan GG; Luesch H; Yoshida WY; Moore RE; Nagle DG; Paul VJ
    J Nat Prod; 1999 Apr; 62(4):655-8. PubMed ID: 10217737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lyngbyastatin 4, a dolastatin 13 analogue with elastase and chymotrypsin inhibitory activity from the marine cyanobacterium Lyngbya confervoides.
    Matthew S; Ross C; Rocca JR; Paul VJ; Luesch H
    J Nat Prod; 2007 Jan; 70(1):124-7. PubMed ID: 17253864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyngbyastatin 2 and norlyngbyastatin 2, analogues of dolastatin G and nordolastatin G from the marine cyanobacterium Lyngbya majuscula.
    Luesch H; Yoshida WY; Moore RE; Paul VJ
    J Nat Prod; 1999 Dec; 62(12):1702-6. PubMed ID: 10654420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dragonamides C and D, linear lipopeptides from the marine cyanobacterium brown Lyngbya polychroa.
    Gunasekera SP; Ross C; Paul VJ; Matthew S; Luesch H
    J Nat Prod; 2008 May; 71(5):887-90. PubMed ID: 18393465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoides.
    Harrigan GG; Luesch H; Yoshida WY; Moore RE; Nagle DG; Paul VJ; Mooberry SL; Corbett TH; Valeriote FA
    J Nat Prod; 1998 Sep; 61(9):1075-7. PubMed ID: 9748368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micromide and guamamide: cytotoxic alkaloids from a species of the marine cyanobacterium Symploca.
    Williams PG; Yoshida WY; Moore RE; Paul VJ
    J Nat Prod; 2004 Jan; 67(1):49-53. PubMed ID: 14738385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Besarhanamides A and B from the marine cyanobacterium Lyngbya majuscula.
    Tan LT; Chang YY; Ashootosh T
    Phytochemistry; 2008 Jul; 69(10):2067-9. PubMed ID: 18514238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yanucamides A and B, two new depsipeptides from an assemblage of the marine cyanobacteria Lyngbya majuscula and Schizothrix species.
    Sitachitta N; Williamson RT; Gerwick WH
    J Nat Prod; 2000 Feb; 63(2):197-200. PubMed ID: 10691708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lyngbyastatins 5-7, potent elastase inhibitors from Floridian marine cyanobacteria, Lyngbya spp.
    Taori K; Matthew S; Rocca JR; Paul VJ; Luesch H
    J Nat Prod; 2007 Oct; 70(10):1593-600. PubMed ID: 17910513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The guineamides, novel cyclic depsipeptides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya majuscula.
    Tan LT; Sitachitta N; Gerwick WH
    J Nat Prod; 2003 Jun; 66(6):764-71. PubMed ID: 12828459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New lipopeptides from the Caribbean cyanobacterium Lyngbya majuscula.
    Jiménez JI; Scheuer PJ
    J Nat Prod; 2001 Feb; 64(2):200-3. PubMed ID: 11430000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New acylated sulfoglycolipids and digalactolipids and related known glycolipids from cyanobacteria with a potential to inhibit the reverse transcriptase of HIV-1.
    Reshef V; Mizrachi E; Maretzki T; Silberstein C; Loya S; Hizi A; Carmeli S
    J Nat Prod; 1997 Dec; 60(12):1251-60. PubMed ID: 9428159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microcolins A and B, new immunosuppressive peptides from the blue-green alga Lyngbya majuscula.
    Koehn FE; Longley RE; Reed JK
    J Nat Prod; 1992 May; 55(5):613-9. PubMed ID: 1517734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula.
    McPhail KL; Correa J; Linington RG; Gonzalez J; Ortega-Barría E; Capson TL; Gerwick WH
    J Nat Prod; 2007 Jun; 70(6):984-8. PubMed ID: 17441769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.